ACT MySelf, was developed by Biogen in collaboration with people living with MS, the MS Trust, a team […]
These proteins control various aspects of RNA biology and represent a new target for cancer treatment
However, the trial did have limitations, researchers note
Pierre Fabre’s Braftovi in combination with Erbitux is the first licensed therapy for a specific subset of colorectal […]
Researchers have developed new software that can be integrated with existing hardware to enable people using robotic prosthetics […]
It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is […]
Updated Date: Wed, 27 May 2020 00:00:00 EDT
Updated Date: Wed, 27 May 2020 00:00:00 EDT
Updated Date: Wed, 27 May 2020 00:00:00 EDT
